Insulet Corporation Initiates Voluntary Correction for Certain Omnipod Devices
Insulet Corporation (NASDAQ:PODD) announced a voluntary correction for specific lots of its Omnipod devices due to a manufacturing issue that could lead to insufficient insulin delivery. The company identified the problem during monitoring, which may result in serious medical conditions such as diabetic ketoacidosis.
Tickers: $PODD
Topics: insulin delivery systems medical devices voluntary correction